Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase II Study of Ivonescimab as Monotherapy or in Combination With Platinum/Pemetrexed Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Harboring Actionable Genomic Alterations (AGAs)

The goal of this clinical trial is to assess the efficacy of ivonescimab monotherapy in patients with advanced non-small cell lung cancer harboring actionable …

Lung Cancer (NSCLC)Lung Cancer Non-Small Cell Cancer (NSCLC)Lung Cancer (Non-Small Cell)+3 more

Massachusetts General HospitalNCT07405190